Currently, the HIV treatment scheme for people in the early stages is a Tenofovir and Lamivudine tablet, combined with Dolutegravir, which is a more recent antiretroviral medication.
The treatment for AIDS is distributed free of charge by SUS, and the registration of patients with SUS is mandatory for the dispensation of antiretroviral drugs, as well as the presentation of a medical prescription.
How to use
The recommended dose is 1 tablet a day, orally, with or without food. Treatment should not be interrupted without the doctor's knowledge.
What happens if I stop treatment?
The irregular use of antiretrovirals, as well as the interruption of treatment, can lead to the resistance of the virus to these drugs, which can render the treatment ineffective. In order to facilitate adherence to therapy, the person must adjust the medication intake times to their daily routine.
Who should not use
This medication is contraindicated for people with hypersensitivity to any of the components of the formula. In addition, this medicine should not be used by pregnant women, women who are breastfeeding or children under the age of 18, unless recommended by the doctor.
Possible side effects
The most common adverse reactions that may occur during treatment with tenofovir and lamivudine are vertigo, gastrointestinal disorders, the appearance of red spots and plaques on the body accompanied by itching, headache, muscle pain, diarrhea, depression, weakness and nausea.
In addition, although it is more rare, vomiting, dizziness and excess intestinal gas may also occur.
